Answers are grounded in this paper and cite their sources.
HBeAg-negative patients with persistently normal ALT are not a homogenous group, and those with high-normal ALT share some of the characteristics that have been associated with adverse long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: